NU SKIN ENTERPRISES INC
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
| ITEM 5. | OTHER INFORMATION |
Consulting Agreement with Joseph Y. Chang
On March 28, 2024, we entered into a consulting agreement (the “Agreement”), effective as of March 30, 2024, with Joseph Y. Chang, who served as the Company’s Chief Scientific Officer until March 30, 2024. The Agreement provides that Dr. Chang will serve as a consultant for a four-year term and will receive consulting fees of $287,500 per year. Dr. Chang will also receive a payment of $500 each month for medical insurance, as well as certain other benefits. The Agreement provides that Dr. Chang will be bound by non-competition, non-solicitation, non-endorsement and non-disparagement covenants. The foregoing description of the Agreement is not intended to be complete and is qualified in its entirety by reference to the full text of the Agreement, which is filed as Exhibit 10.1 to this report.
Trading Plans
None.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.